Free tool
Stocks listed on Nasdaq GS
We cover 214 companies listed on Nasdaq GS. The median market value in the group is $856.19M. Across the group, the median move over the past trading day is −0.41%. 64% of the 203 with a 200-day average trade above it. Price change over the past year runs from −40.1% to +158.7% across the middle 80 percent of the group, with a median of +18.5%. Across the group, 1 company currently carries a tier A volume signal.
Other lists in this group
Table
214 of 1,279 companies match these filters.Clear filters
| Ticker | Company | Market cap (USD) | Size | 1Y return |
|---|---|---|---|---|
| GILD | Gilead Sciences, Inc. | $184.47B | Large cap | +32.51% |
| VRTX | Vertex Pharmaceuticals Incorporated | $138.63B | Large cap | +40.66% |
| ISRG | Intuitive Surgical, Inc. | $133.22B | Large cap | −21.38% |
| SNY | Sanofi | $108.83B | Large cap | −4.33% |
| REGN | Regeneron Pharmaceuticals, Inc. | $83.89B | Large cap | +39.36% |
| ARGX | argenx SE | $65.51B | Large cap | +47.90% |
| MRNA | Moderna, Inc. | $59.75B | Large cap | +496.25% |
| NTRA | Natera, Inc. | $48.53B | Large cap | +107.59% |
| MDLN | Medline Inc. | $46.53B | Large cap | −13.07% |
| RVMD | Revolution Medicines, Inc. | $46.18B | Large cap | +466.35% |
| IDXX | IDEXX Laboratories, Inc. | $43.66B | Large cap | −13.64% |
| ONC | BeOne Medicines AG | $42.58B | Large cap | +25.21% |
| RPRX | Royalty Pharma plc | $35.71B | Large cap | +74.00% |
| ILMN | Illumina, Inc. | $33.95B | Large cap | +125.88% |
| DXCM | DexCom, Inc. | $33.65B | Large cap | +16.47% |
| GEHC | GE HealthCare Technologies Inc. | $33.35B | Large cap | −1.15% |
| BIIB | Biogen Inc. | $32.66B | Large cap | +62.12% |
| ALNY | Alnylam Pharmaceuticals, Inc. | $32.12B | Large cap | −47.38% |
| BNTX | BioNTech SE | $28.28B | Large cap | +9.27% |
| INSM | Insmed Incorporated | $27.16B | Large cap | −7.54% |
| ROIV | Roivant Sciences Ltd. | $26.55B | Large cap | +206.51% |
| INCY | Incyte Corporation | $25.97B | Large cap | +51.01% |
| GH | Guardant Health, Inc. | $22.94B | Large cap | +169.17% |
| GMAB | Genmab A/S | $21.42B | Large cap | +36.20% |
| VTRS | Viatris Inc. | $19.35B | Large cap | +66.19% |
| MEDP | Medpace Holdings, Inc. | $17.28B | Large cap | +30.74% |
| JAZZ | Jazz Pharmaceuticals plc | $16.89B | Large cap | +100.35% |
| ASND | Ascendis Pharma A/S | $16.41B | Large cap | +29.66% |
| NBIX | Neurocrine Biosciences, Inc. | $15.92B | Large cap | +13.36% |
| BBIO | BridgeBio Pharma, Inc. | $15.52B | Large cap | +60.05% |
| COO | The Cooper Companies, Inc. | $14.25B | Large cap | −1.93% |
| EXEL | Exelixis, Inc. | $14.05B | Large cap | +45.68% |
| ICLR | ICON Public Limited Company | $13.03B | Large cap | −2.91% |
| BMRN | BioMarin Pharmaceutical Inc. | $12.70B | Large cap | +11.85% |
| ARWR | Arrowhead Pharmaceuticals, Inc. | $12.52B | Large cap | +308.99% |
| MDGL | Madrigal Pharmaceuticals, Inc. | $12.45B | Large cap | +26.78% |
| HALO | Halozyme Therapeutics, Inc. | $12.41B | Large cap | +46.30% |
| TEM | Tempus AI, Inc. | $12.40B | Large cap | −6.49% |
| TECH | Bio-Techne Corporation | $11.35B | Large cap | +29.33% |
| BTSG | BrightSpring Health Services, Inc. | $11.32B | Large cap | +156.37% |
| ALGN | Align Technology, Inc. | $11.31B | Large cap | +12.09% |
| CYTK | Cytokinetics, Incorporated | $11.01B | Large cap | +109.36% |
| KRYS | Krystal Biotech, Inc. | $10.65B | Large cap | +143.67% |
| IONS | Ionis Pharmaceuticals, Inc. | $10.56B | Large cap | +48.21% |
| PRAX | Praxis Precision Medicines, Inc. | $10.54B | Large cap | +704.28% |
| ENSG | The Ensign Group, Inc. | $10.43B | Large cap | +5.01% |
| HSIC | Henry Schein, Inc. | $10.30B | Large cap | +31.02% |
| RGEN | Repligen Corporation | $10.25B | Large cap | +51.67% |
| PGNY | Progyny, Inc. | $1.98B | Small cap | +14.55% |
| TSHA | Taysha Gene Therapies, Inc. | $1.96B | Small cap | +102.69% |
| IMCR | Immunocore Holdings plc | $1.93B | Small cap | +13.69% |
| LKFT | Lakefront Biotherapeutics NV | $1.91B | Small cap | −11.39% |
| VIR | Vir Biotechnology, Inc. | $1.87B | Small cap | +111.85% |
| RXRX | Recursion Pharmaceuticals, Inc. | $1.87B | Small cap | −28.63% |
| SGRY | Surgery Partners, Inc. | $1.84B | Small cap | −38.48% |
| INBX | Inhibrx Biosciences, Inc. | $1.81B | Small cap | +357.45% |
| SNDX | Syndax Pharmaceuticals, Inc. | $1.77B | Small cap | +23.55% |
| FTRE | Fortrea Holdings Inc. | $1.76B | Small cap | +105.20% |
| ANAB | AnaptysBio, Inc. | $1.73B | Small cap | +326.47% |
| AVLN | Avalyn Pharma Inc. | $1.64B | Small cap | +25.60% |
| XERS | Xeris Biopharma Holdings, Inc. | $1.58B | Small cap | +8.64% |
| ABSI | Absci Corporation | $1.58B | Small cap | +261.57% |
| TRAX | First Tracks Biotherapeutics, Inc. | $1.58B | Small cap | +132.58% |
| HCSG | Healthcare Services Group, Inc. | $1.57B | Small cap | +47.05% |
| TYRA | Tyra Biosciences, Inc. | $1.56B | Small cap | +103.57% |
| KMTS | Kestra Medical Technologies, Ltd. | $1.56B | Small cap | +47.61% |
| INVA | Innoviva, Inc. | $1.53B | Small cap | +7.06% |
| OMCL | Omnicell, Inc. | $1.53B | Small cap | +0.66% |
| NVAX | Novavax, Inc. | $1.52B | Small cap | +21.50% |
| REPL | Replimune Group, Inc. | $1.50B | Small cap | +187.16% |
| SPTX | Seaport Therapeutics, Inc. | $1.49B | Small cap | +40.32% |
| INNV | InnovAge Holding Corp. | $1.48B | Small cap | +178.79% |
| CGEM | Cullinan Therapeutics, Inc. | $1.48B | Small cap | +188.15% |
| AKTS | Aktis Oncology, Inc. | $1.47B | Small cap | +18.35% |
| AZTA | Azenta, Inc. | $1.47B | Small cap | +11.16% |
| OMDA | Omada Health, Inc. | $1.47B | Small cap | +2.74% |
| SDGR | Schrödinger, Inc. | $1.46B | Small cap | −1.62% |
| ATEC | Alphatec Holdings, Inc. | $1.45B | Small cap | −41.78% |
| ORIC | ORIC Pharmaceuticals, Inc. | $1.44B | Small cap | +35.58% |
| MGTX | MeiraGTx Holdings plc | $1.43B | Small cap | +100.54% |
| PNTG | The Pennant Group, Inc. | $1.34B | Small cap | +56.31% |
| IART | Integra LifeSciences Holdings Corporation | $1.31B | Small cap | +13.52% |
| VOR | Vor Biopharma Inc. | $1.30B | Small cap | −40.82% |
| SANA | Sana Biotechnology, Inc. | $1.25B | Small cap | +23.44% |
| GDRX | GoodRx Holdings, Inc. | $1.25B | Small cap | −18.89% |
| CERT | Certara, Inc. | $1.24B | Small cap | −25.07% |
| GLUE | Monte Rosa Therapeutics, Inc. | $1.23B | Small cap | +207.92% |
| KURA | Kura Oncology, Inc. | $1.16B | Small cap | +66.16% |
| SVRA | Savara Inc. | $1.15B | Small cap | +70.52% |
| LMRI | Lumexa Imaging Holdings, Inc. | $1.15B | Small cap | −35.42% |
| OPK | OPKO Health, Inc. | $1.11B | Small cap | +6.34% |
| SLDB | Solid Biosciences Inc. | $1.04B | Small cap | +72.95% |
| ABUS | Arbutus Biopharma Corporation | $1.03B | Small cap | +42.19% |
| QDEL | QuidelOrtho Corporation | $1.02B | Small cap | −46.31% |
| PCRX | Pacira BioSciences, Inc. | $1.02B | Small cap | −0.88% |
| GERN | Geron Corporation | $995.83M | Small cap | +8.51% |
| DSGN | Design Therapeutics, Inc. | $975.65M | Small cap | +194.71% |
| BVS | Bioventus Inc. | $954.22M | Small cap | +86.52% |
| OLMA | Olema Pharmaceuticals, Inc. | $949.35M | Small cap | +89.02% |
| ANNX | Annexon, Inc. | $946.00M | Small cap | +136.49% |
| AMPH | Amphastar Pharmaceuticals, Inc. | $934.98M | Small cap | −27.78% |
| ACRS | Aclaris Therapeutics, Inc. | $911.16M | Small cap | +240.11% |
| CBLL | CeriBell, Inc. | $899.97M | Small cap | +102.16% |
| SGP | SpyGlass Pharma, Inc. | $891.05M | Small cap | +0.91% |
| RIGL | Rigel Pharmaceuticals, Inc. | $864.97M | Small cap | +16.99% |
| INMD | InMode Ltd. | $864.89M | Small cap | −1.71% |
| FDMT | 4D Molecular Therapeutics, Inc. | $859.60M | Small cap | +140.87% |
| COLL | Collegium Pharmaceutical, Inc. | $852.79M | Small cap | −29.08% |
| HSTM | HealthStream, Inc. | $840.94M | Small cap | +1.86% |
| STTK | Shattuck Labs, Inc. | $792.87M | Small cap | +690.00% |
| VREX | Varex Imaging Corporation | $778.90M | Small cap | +61.40% |
| SOPH | SOPHiA GENETICS SA | $726.14M | Small cap | +156.16% |
| CTMX | CytomX Therapeutics, Inc. | $723.43M | Small cap | +60.39% |
| ASMB | Assembly Biosciences, Inc. | $721.17M | Small cap | +36.81% |
| PHAT | Phathom Pharmaceuticals, Inc. | $709.50M | Small cap | −29.50% |
| IRWD | Ironwood Pharmaceuticals, Inc. | $708.88M | Small cap | +240.48% |
| ALLO | Allogene Therapeutics, Inc. | $704.80M | Small cap | +75.86% |
| AGMB | AgomAb Therapeutics NV | $703.26M | Small cap | −2.53% |
| ZVRA | Zevra Therapeutics, Inc. | $697.17M | Small cap | +25.43% |
| EVO | Evotec SE | $693.01M | Small cap | −44.13% |
| EIKN | Eikon Therapeutics, Inc. | $679.77M | Small cap | −20.13% |
| ANGO | AngioDynamics, Inc. | $648.51M | Small cap | +56.74% |
| CTNM | Contineum Therapeutics, Inc. | $640.31M | Small cap | +70.03% |
| TLRY | Tilray Brands, Inc. | $638.38M | Small cap | −66.13% |
| VALN | Valneva SE | $634.84M | Small cap | −23.49% |
| AUTL | Autolus Therapeutics plc | $620.16M | Small cap | +48.41% |
| ARVN | Arvinas, Inc. | $609.40M | Small cap | +15.35% |
| MPLT | MapLight Therapeutics, Inc. | $596.42M | Small cap | −29.88% |
| CTKB | Cytek Biosciences, Inc. | $594.02M | Small cap | +11.74% |
| RGNX | REGENXBIO Inc. | $588.18M | Small cap | +6.35% |
| KYTX | Kyverna Therapeutics, Inc. | $546.70M | Small cap | +133.33% |
| CABA | Cabaletta Bio, Inc. | $545.94M | Small cap | +116.67% |
| PRLD | Prelude Therapeutics Incorporated | $522.47M | Small cap | +412.50% |
| CCCC | C4 Therapeutics, Inc. | $521.63M | Small cap | +64.34% |
| SENS | Senseonics Holdings, Inc. | $493.84M | Small cap | +0.43% |
| CGC | Canopy Growth Corporation | $492.21M | Small cap | −31.46% |
| EDIT | Editas Medicine, Inc. | $488.38M | Small cap | +19.10% |
| NRC | NRC Health | $487.06M | Small cap | +45.92% |
| PACB | Pacific Biosciences of California, Inc. | $484.90M | Small cap | +17.29% |
| KMDA | Kamada Ltd. Ordinary Shares | $483.48M | Small cap | +21.09% |
| CAPR | Capricor Therapeutics, Inc. | $481.97M | Small cap | +49.76% |
| PRTA | Prothena Corporation plc | $474.87M | Small cap | +8.06% |
| PBYI | Puma Biotechnology, Inc. | $472.84M | Small cap | +79.61% |
| SGHT | Sight Sciences, Inc. | $458.33M | Small cap | +97.87% |
| BIOA | BioAge Labs, Inc. | $451.63M | Small cap | +107.59% |
| AVIR | Atea Pharmaceuticals, Inc. | $441.93M | Small cap | +53.06% |
| CARL | Carlsmed, Inc. | $441.76M | Small cap | +16.40% |
| CCRN | Cross Country Healthcare Inc | $428.06M | Small cap | +0.38% |
| ENTA | Enanta Pharmaceuticals, Inc. | $412.12M | Small cap | +65.89% |
| OFIX | Orthofix Medical Inc. | $397.14M | Small cap | −34.30% |
| UPB | Upstream Bio, Inc. | $390.52M | Small cap | −57.31% |
| MOBI | Mobia Medical, Inc. | $387.35M | Small cap | −0.85% |
| SLP | Simulations Plus, Inc. | $372.34M | Small cap | +28.20% |
| LYEL | Lyell Immunopharma, Inc. | $362.68M | Small cap | +37.32% |
| IFRX | InflaRx N.V. | $356.63M | Small cap | +142.00% |
| TMCI | Treace Medical Concepts, Inc. | $306.96M | Small cap | −36.39% |
| BCYC | Bicycle Therapeutics plc | $304.03M | Small cap | −37.79% |
| AVXL | Anavex Life Sciences Corp. | $300.34M | Small cap | −65.71% |
| MYGN | Myriad Genetics, Inc. | $298.43M | Small cap | −47.39% |
| NMRA | Neumora Therapeutics, Inc. | $293.12M | Small cap | −11.36% |
| ANIK | Anika Therapeutics, Inc. | $290.14M | Small cap | +136.17% |
| EMBC | Embecta Corp. | $285.00M | Small cap | −64.70% |
| PYXS | Pyxis Oncology, Inc. | $278.58M | Small cap | +145.59% |
| ALXO | ALX Oncology Holdings Inc. | $273.79M | Small cap | +65.00% |
| ALEC | Alector, Inc. | $263.51M | Small cap | +2.50% |
| MGNX | MacroGenics, Inc. Common Stock | $257.35M | Small cap | +134.88% |
| OSUR | OraSure Technologies, Inc. | $255.87M | Small cap | +11.08% |
| LAB | Standard BioTools Inc. | $255.18M | Small cap | −49.08% |
| IPHA | Innate Pharma S.A. | $253.56M | Small cap | +2.86% |
| PEPG | PepGen Inc. | $237.21M | Small cap | +159.68% |
| RNA | Prosensa Holding B.V. Ordinary Shares | $236.91M | Small cap | −6.10% |
| TNXP | Tonix Pharmaceuticals Holding Corp. Common Stock | $233.94M | Small cap | −57.61% |
| UTMD | Utah Medical Products, Inc. | $225.70M | Small cap | +17.76% |
| SPOK | Spok Holdings, Inc. | $217.86M | Small cap | −36.39% |
| ABOS | Acumen Pharmaceuticals, Inc. | $216.23M | Small cap | +115.11% |
| VYGR | Voyager Therapeutics, Inc. | $213.20M | Small cap | +1.17% |
| ANTX | AN2 Therapeutics, Inc. | $208.68M | Small cap | +385.09% |
| NKTX | Nkarta, Inc. | $194.10M | Small cap | +17.41% |
| HUMA | Humacyte, Inc. | $189.35M | Small cap | −55.45% |
| CDXS | Codexis, Inc. | $180.68M | Small cap | −38.20% |
| OGI | Organigram Global Inc. | $177.67M | Small cap | −24.55% |
| LFCR | Lifecore Biomedical, Inc. | $176.02M | Small cap | −38.25% |
| MOLN | Molecular Partners AG | $170.46M | Small cap | +18.67% |
| AARD | Aardvark Therapeutics, Inc. | $149.04M | Small cap | −24.25% |
| INGN | Inogen, Inc. | $147.55M | Small cap | −29.89% |
| MIST | Milestone Pharmaceuticals Inc. | $146.91M | Small cap | −33.33% |
| LENZ | LENZ Therapeutics, Inc. | $146.73M | Small cap | −87.21% |
| MXCT | MaxCyte, Inc. | $139.33M | Small cap | −6.43% |
| BDTX | Black Diamond Therapeutics, Inc. | $130.42M | Small cap | −20.91% |
| CPIX | Cumberland Pharmaceuticals Inc. | $130.35M | Small cap | +163.82% |
| APYX | Apyx Medical Corporation | $128.48M | Small cap | +54.04% |
| BMEA | Biomea Fusion, Inc. | $123.95M | Small cap | −8.06% |
| HCAT | Health Catalyst, Inc. | $118.91M | Small cap | −56.91% |
| SEER | Seer, Inc. | $112.96M | Small cap | −1.94% |
| LUNG | Pulmonx Corporation | $105.59M | Small cap | +34.41% |
| ATRA | Atara Biotherapeutics, Inc. | $94.15M | Micro cap | −24.05% |
| CVRX | CVRx, Inc. | $87.12M | Micro cap | −56.75% |
| GOSS | Gossamer Bio, Inc. | $85.01M | Micro cap | −92.93% |
| DH | Definitive Healthcare Corp. | $84.34M | Micro cap | −80.44% |
| OM | Outset Medical, Inc. | $79.89M | Micro cap | −69.56% |
| PLRX | Pliant Therapeutics, Inc. | $73.69M | Micro cap | −31.36% |
| SPRO | Spero Therapeutics, Inc. | $71.05M | Micro cap | −38.38% |
| XBIT | XBiotech Inc. | $70.43M | Micro cap | −33.62% |
| PMVP | PMV Pharmaceuticals, Inc. | $70.03M | Micro cap | −7.75% |
| BOLD | Boundless Bio, Inc. | $66.31M | Micro cap | +155.70% |
| MCRB | Seres Therapeutics, Inc. | $47.81M | Micro cap | −74.79% |
| MGX | Metagenomi Therapeutics, Inc. | $46.09M | Micro cap | −34.41% |
| KPTI | Karyopharm Therapeutics Inc. Common Stock | $44.46M | Micro cap | −74.90% |
| PETS | PetMed Express, Inc. | $38.81M | Micro cap | −43.35% |
| KYNB | Kyntra Bio, Inc. | $32.82M | Micro cap | −22.66% |
| QNCX | Quince Therapeutics, Inc. | $31.84M | Micro cap | +100.71% |
| NXTC | NextCure, Inc. | $27.05M | Micro cap | +11.37% |
| TXMD | TherapeuticsMD, Inc. | $26.39M | Micro cap | +103.57% |
| TRIB | Trinity Biotech plc | $7.80M | Micro cap | +547.97% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.